Clinical Trials List
Protocol NumberMK-1026-008
Active
2022-12-01 - 2031-12-31
Phase III
Recruiting3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Chien-Chin Lin 無
- Wen-Chien Chou 無
- Huai-Hsuan Huang 無
- 田豐銘 無
- Tai-Chung Huang 無
- Chieh-Lung Cheng 無
- - - 無
- CHENG-HONG TSAI 無
- MING YAO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu 未分科
- Chih-Chieh Yen 未分科
- Chun-Hui Lee 未分科
- Ya-Ping Chen 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
300 participants
